ScreenerHero

IART Integra LifeSciences Holdings Corporation

NAS · US · Healthcare · Medical Devices · integralife.com
13.00USD-2.40%Mkt Cap: 1.01B $P/E: —

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operate…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$171.97BUSDP/E 31.8
MDT
Medtronic plc
$109.38BUSDP/E 21.0
SYK
Stryker Corporation
$105.64BUSDP/E 28.5
BSX
Boston Scientific Corporation
$60.26BUSDP/E 16.8
EW
Edwards Lifesciences Corporation
$49.39BUSDP/E 51.1
SHL
Siemens Healthineers AG
$46.91BUSDP/E 19.6
DXCM
DexCom, Inc.
$31.81BUSDP/E 33.5
GEHC
GE HealthCare Technologies Inc.
$29.42BUSDP/E 14.9
PHG
Koninklijke Philips N.V.
$23.55BUSDP/E 18.0
PHIA
Koninklijke Philips N.V.
$22.87BUSDP/E 18.7
STE
STERIS plc
$20.44BUSDP/E 25.6
SOON
Sonova Holding AG
$17.11BUSDP/E 28.0
ZBH
Zimmer Biomet Holdings, Inc.
$16.88BUSDP/E 21.5
PEN
Penumbra, Inc.
$12.46BUSDP/E 77.7
SNN
Smith & Nephew plc
$11.25BUSDP/E 18.3
GKOS
Glaukos Corporation
$10.16BUSD
DEMANT
Demant A/S
$9.87BUSDP/E 28.0
TXG
10x Genomics, Inc.
$9.92BUSD
GMED
Globus Medical, Inc.
$9.90BUSDP/E 18.9
BIO
Bio-Rad Laboratories, Inc.
$9.85BUSDP/E 46.6

Key Statistics

Company
Market Cap1.01B USD
Enterprise Value2.81B USD
Revenue (TTM)1.65B USD
Gross Profit831.62M USD
Net Income (TTM)-516.47M USD
Revenue/Share21.41 USD
Last Price13.00 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4.4K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)5.14
PEG0.67
EV/EBITDA8.87
EV/Revenue1.71
P/S0.63
P/B0.99
EPS (TTM)-0.09
EPS (Forward)2.59
52W Range
8.70036% of range20.49
52W High20.49 USD
52W Low8.700 USD
Profitability
Gross Margin50.86%
Oper. Margin9.62%
EBITDA Margin19.23%
Profit Margin-31.58%
ROE-49.50%
ROA-14.34%
Growth
Revenue Growth0.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF50.38M USD
CapEx (TTM)95.64M USD
FCF Margin5.73%
FCF Yield9.34%
Net Debt1.78B USD
Net Debt/EBITDA5.60
Balance Sheet
Debt/Equity1.95
Current Ratio3.60
Quick Ratio1.64
Book Value/Sh13.41 USD
Cash/Share3.52 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateJan 4, 2017
Analyst Consensus
Rating2.7 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)18.38 USD
Upside (mean)+41.3%
Target Range14.00 USD – 27.00 USD
14.00+41.3% to mean27.00
# Analysts8
Ownership
Shares Out.77.77M
Float58.65M
Insiders14.33%
Institutions98.67%
Short Interest
Short Ratio9.8d
Short % Float12.07%
Short % Out.8.75%
Shares Short6.81M
Short (prev mo.)6.74M
Technical
SMA 5016.49 (-21.2%)
SMA 20014.05 (-7.5%)
Beta1.21
S&P 52W Chg16.45%
Avg Vol (30d)940.51K
Avg Vol (10d)1.07M
Technical Indicators
RSI (14)31.1
MACD-0.8547
MACD Signal-0.5752
MACD Hist.-0.2795
BB Upper17.82 USD
BB Middle15.36 USD
BB Lower12.90 USD
BB Width32.00%
ATR (14)0.8610 USD
Vol Ratio (20d)1.33x